External validation of a multi-institutional retroperitoneal sarcoma nomogram

Background: A multi-institutional nomogram for predicting disease-free survival (DFS) and overall survival (OS) in patients with primary retroperitoneal sarcoma (RPS) incorporating relevant prognostic factors not included in the American Joint Committee on Cancer staging system for soft tissue sarco...

Full description

Saved in:
Bibliographic Details
Main Authors: Raut, Chandrajit P. (Author) , Hohenberger, Peter (Author) , Jakob, Jens (Author)
Format: Article (Journal)
Language:English
Published: February 24, 2016
In: Cancer
Year: 2016, Volume: 122, Issue: 9, Pages: 1417-1424
ISSN:1097-0142
DOI:10.1002/cncr.29931
Online Access:Verlag, Volltext: https://doi.org/10.1002/cncr.29931
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.29931
Get full text
Author Notes:Chandrajit P. Raut, MD, MSc; Rosalba Miceli, PhD; Dirk C. Strauss, MD; Carol J. Swallow, MD, PhD; Peter Hohenberger, MD; Frits van Coevorden, MD; Piotr Rutkowski, MD; Marco Fiore, MD; Dario Callegaro, MD; Paolo G. Casali, MD; Rick L. Haas, MD; Andrew J. Hayes, MD; Charles Honore, MD; Amanda J. Cannell, BS; Jens Jakob, MD; Milena Szacht, MD, PhD; Mark Fairweather, MD; Raphael E. Pollock, MD, PhD; Sylvie Bonvalot, MD and Alessandro Gronchi, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1665542764
003 DE-627
005 20230426084932.0
007 cr uuu---uuuuu
008 190514s2016 xx |||||o 00| ||eng c
024 7 |a 10.1002/cncr.29931  |2 doi 
035 |a (DE-627)1665542764 
035 |a (DE-599)KXP1665542764 
035 |a (OCoLC)1341213069 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Raut, Chandrajit P.  |e VerfasserIn  |0 (DE-588)1186103736  |0 (DE-627)1665542527  |4 aut 
245 1 0 |a External validation of a multi-institutional retroperitoneal sarcoma nomogram  |c Chandrajit P. Raut, MD, MSc; Rosalba Miceli, PhD; Dirk C. Strauss, MD; Carol J. Swallow, MD, PhD; Peter Hohenberger, MD; Frits van Coevorden, MD; Piotr Rutkowski, MD; Marco Fiore, MD; Dario Callegaro, MD; Paolo G. Casali, MD; Rick L. Haas, MD; Andrew J. Hayes, MD; Charles Honore, MD; Amanda J. Cannell, BS; Jens Jakob, MD; Milena Szacht, MD, PhD; Mark Fairweather, MD; Raphael E. Pollock, MD, PhD; Sylvie Bonvalot, MD and Alessandro Gronchi, MD 
264 1 |c February 24, 2016 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.05.2019 
520 |a Background: A multi-institutional nomogram for predicting disease-free survival (DFS) and overall survival (OS) in patients with primary retroperitoneal sarcoma (RPS) incorporating relevant prognostic factors not included in the American Joint Committee on Cancer staging system for soft tissue sarcoma has been reported. The authors validated this nomogram with an independent, transatlantic cohort. Methods: Data from patients with RPS who were undergoing definitive resection at 1 of 6 sarcoma centers in Europe and North America (“validation set”) were used to validate a RPS nomogram developed from 3 other centers (“development set”). The nomogram incorporated 6 variables: age, tumor size, grade, histologic subtype, multifocality, and quality of surgery. Nomogram-predicted probabilities were stratified into 6 subgroups and compared with observed outcomes. Discriminative ability was quantified by Harrell C statistics. Results: The validation and development sets included 631 and 523 patients, respectively, all of whom underwent surgical resection at the institutions represented. The 7-year DFS and OS rates for the validation set were 38% (95% confidence interval, 34%-43%) and 58% (95% confidence interval, 53%-63%), respectively. All 6 nomogram variables were found to be independently prognostic. The corrected Harrell C statistics concordance index values for the validation set were 0.69 for DFS and 0.73 for OS, which were similar to those for the development set, suggesting good calibration of the nomogram in the validation cohort. Conclusions: The RPS nomogram was externally validated using a larger, independent cohort. The nomogram can be generalized to patients undergoing surgery for RPS by specialized sarcoma surgeons at sarcoma centers. The nomogram provides a more individualized and disease-relevant estimation of OS compared with the American Joint Committee on Cancer classification. 
650 4 |a grade 
650 4 |a histology 
650 4 |a multifocality 
650 4 |a nomogram 
650 4 |a retroperitoneal sarcoma 
650 4 |a staging 
650 4 |a surgery 
700 1 |a Hohenberger, Peter  |d 1953-  |e VerfasserIn  |0 (DE-588)1025311469  |0 (DE-627)72202875X  |0 (DE-576)370195574  |4 aut 
700 1 |a Jakob, Jens  |d 1974-  |e VerfasserIn  |0 (DE-588)129491128  |0 (DE-627)470196335  |0 (DE-576)297687794  |4 aut 
773 0 8 |i Enthalten in  |t Cancer  |d New York, NY : Wiley-Liss, 1948  |g 122(2016), 9, Seite 1417-1424  |h Online-Ressource  |w (DE-627)271350334  |w (DE-600)1479932-7  |w (DE-576)078590884  |x 1097-0142  |7 nnas  |a External validation of a multi-institutional retroperitoneal sarcoma nomogram 
773 1 8 |g volume:122  |g year:2016  |g number:9  |g pages:1417-1424  |g extent:8  |a External validation of a multi-institutional retroperitoneal sarcoma nomogram 
856 4 0 |u https://doi.org/10.1002/cncr.29931  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.29931  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190514 
993 |a Article 
994 |a 2016 
998 |g 129491128  |a Jakob, Jens  |m 129491128:Jakob, Jens  |d 60000  |d 61800  |e 60000PJ129491128  |e 61800PJ129491128  |k 0/60000/  |k 1/60000/61800/  |p 15 
998 |g 1025311469  |a Hohenberger, Peter  |m 1025311469:Hohenberger, Peter  |d 60000  |d 61800  |e 60000PH1025311469  |e 61800PH1025311469  |k 0/60000/  |k 1/60000/61800/  |p 5 
999 |a KXP-PPN1665542764  |e 347582132X 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"External validation of a multi-institutional retroperitoneal sarcoma nomogram","title_sort":"External validation of a multi-institutional retroperitoneal sarcoma nomogram"}],"language":["eng"],"person":[{"family":"Raut","role":"aut","given":"Chandrajit P.","display":"Raut, Chandrajit P."},{"given":"Peter","role":"aut","display":"Hohenberger, Peter","family":"Hohenberger"},{"family":"Jakob","given":"Jens","role":"aut","display":"Jakob, Jens"}],"name":{"displayForm":["Chandrajit P. Raut, MD, MSc; Rosalba Miceli, PhD; Dirk C. Strauss, MD; Carol J. Swallow, MD, PhD; Peter Hohenberger, MD; Frits van Coevorden, MD; Piotr Rutkowski, MD; Marco Fiore, MD; Dario Callegaro, MD; Paolo G. Casali, MD; Rick L. Haas, MD; Andrew J. Hayes, MD; Charles Honore, MD; Amanda J. Cannell, BS; Jens Jakob, MD; Milena Szacht, MD, PhD; Mark Fairweather, MD; Raphael E. Pollock, MD, PhD; Sylvie Bonvalot, MD and Alessandro Gronchi, MD"]},"id":{"doi":["10.1002/cncr.29931"],"eki":["1665542764"]},"physDesc":[{"extent":"8 S."}],"relHost":[{"title":[{"title_sort":"Cancer","title":"Cancer","subtitle":"interdisciplinary international journal of the American Cancer Society"}],"language":["eng"],"part":{"issue":"9","pages":"1417-1424","extent":"8","volume":"122","year":"2016","text":"122(2016), 9, Seite 1417-1424"},"pubHistory":["1.1948 -"],"id":{"issn":["1097-0142"],"zdb":["1479932-7"],"doi":["10.1002/(ISSN)1097-0142"],"eki":["271350334"]},"disp":"External validation of a multi-institutional retroperitoneal sarcoma nomogramCancer","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 06.12.2011"],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Cancer cytopathology"}],"origin":[{"dateIssuedKey":"1948","publisher":"Wiley-Liss","dateIssuedDisp":"1948-","publisherPlace":"New York, NY"}],"recId":"271350334"}],"note":["Gesehen am 14.05.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1665542764","origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"February 24, 2016"}]} 
SRT |a RAUTCHANDREXTERNALVA2420